新型冠状病毒感染相关心肌炎诊断和治疗建议

doi:10.16138/j.1673-6087.2023.01.002

摘要/Abstract

中图分类号:

R542.2

金玮, 杨晨蝶, 王玲洁, 张凤如, 赵强, 吴立群, 张瑞岩. 新型冠状病毒感染相关心肌炎诊断和治疗建议[J]. 内科理论与实践, 2023, 18(01): 5-9.

JIN Wei, YANG Chendie, WANG Lingjie, et al. Recommendations on diagnosis and treatment of myocarditis associated with novel coronavirus infection[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 5-9.

图/表 1

参考文献 18

[1]	Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play[J]. J Am Coll Cardiol, 2022, 79(17): 1717-1756.
[2]	Singer ME, Taub IB, Kaelber DC. Risk of myocarditis from COVID-19 infection in people under age 20[J/OL]. MedRxiv, 2022. https://www.medrxiv.org/content/10.1101/2021.07.23.21260998v2.
[3]	Ammirati E, Lupi L, Palazzini M, et al. Prevalence, cha-racteristics, and outcomes of COVID-19-associated acute myocarditis[J]. Circulation, 2022, 145(15): 1123-1139. doi: 10.1161/CIRCULATIONAHA.121.056817 pmid: 35404682
[4]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. doi: S0140-6736(20)30183-5 pmid: 31986264
[5]	Lala A, Johnson KW, Russak AJ, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection[J]. J Am Coll Cardiol, 2020, 76(5): 533-546. doi: S0735-1097(20)35552-2 pmid: 32517963
[6]	Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069. doi: 10.1001/jama.2020.1585 pmid: 32031570
[7]	Rathore SS, Rojas GA, Sondhi M, et al. Myocarditis associated with Covid-19 disease: a systematic review of published case reports and case series[J]. Int J Clin Pract, 2021, 75(11): e14470.
[8]	Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries[J]. PLoS One, 2020, 15(6): e0234765.
[9]	Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID[J]. Nat Med, 2021, 27(4): 626-631. doi: 10.1038/s41591-021-01292-y pmid: 33692530
[10]	中华医学会心血管病学分会精准医学学组, 中华心血管病杂志编辑委员会, 成人暴发性心肌炎工作组. 成人暴发性心肌炎诊断与治疗中国专家共识[J]. 中华心血管病杂志, 2017, 45(9): 742-752.
[11]	Fayol A, Livrozet M, Boutouyrie P, et al. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study[J]. ESC Heart Fail, 2021, 8(3): 2232-2239.
[12]	国家老年医学中心/国家老年疾病临床医学研究中心, 中国老年医学学会心血管病分会, 北京医学会心血管病学会影像学组. 新型冠状病毒肺炎相关心肌损伤的临床管理专家建议(第一版)[J]. 中国循环杂志, 2020, 35(4): 326-330.
[13]	Kelle S, Bucciarelli-Ducci C, Judd RM, et al. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection[J]. J Cardiovasc Magn Reson, 2020, 22(1): 61. doi: 10.1186/s12968-020-00656-6 URL
[14]	Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis[J]. Eur Heart J, 2013, 34(33): 2636-2648. doi: 10.1093/eurheartj/eht210 pmid: 23824828
[15]	Seferoviéc PM, Tsutsui H, Mcnamara DM, et al. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society position statement on endomyocardial biopsy[J]. J Card Fail, 2021, 27(7): 727-743. doi: 10.1016/j.cardfail.2021.04.010 URL
[16]	Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology[J]. J Am Coll Cardiol, 2007, 50(19): 1914-1931. doi: 10.1016/j.jacc.2007.09.008 pmid: 17980265
[17]	国务院联防联控机制综合组. 关于印发新型冠状病毒感染防控方案(第十版)的通知[EB/OL]. 2023. http://www.gov.cn/xinwen/202301/07/content_5735448.htm.
[18]	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2022, 79(17): e263-e421. doi: 10.1016/j.jacc.2021.12.012 pmid: 35379503

新型冠状病毒感染相关心肌炎诊断和治疗建议

Recommendations on diagnosis and treatment of myocarditis associated with novel coronavirus infection

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 18

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴晓静, 王伟铭. 血液透析患者合并新型冠状病毒感染瑞金医院诊治建议（2023版）[J]. 内科理论与实践, 2023, 18(01): 34-35.
[2]	庄蕾, 金瑞, 高卫益, 陈尔真, 赵强, 瞿介明. 瑞金医院新型冠状病毒感染患者院内专家巡视诊疗工作方案[J]. 内科理论与实践, 2023, 18(01): 36-37.
[3]	虞佩, 周帅, 成杰, 高卫益, 陈尔真, 宁光, 瞿介明. 面对激增的新型冠状病毒感染患者瑞金医院门急诊工作布局调整方案[J]. 内科理论与实践, 2023, 18(01): 38-39.
[4]	陆聆韵, 郑岚. 瑞金医院中医辨治新型冠状病毒疫病[J]. 内科理论与实践, 2023, 18(01): 40-41.
[5]	张惟郁, 郑岚, 郑炜华, 刘嘉琳, 吕玲玲, 陆聆韵, 杨翠萍, 李琼. 新型冠状病毒奥密克戎变异株感染轻型患者的中医证候特点[J]. 内科理论与实践, 2023, 18(01): 48-50.
[6]	瞿介明, 时国朝, 李庆云, 周敏, 程齐俭, 陈巍, 冯耘, 周剑平. 瑞金医院新型冠状病毒肺炎诊治简明方案（2023年1月版）[J]. 内科理论与实践, 2023, 18(01): 1-4.
[7]	中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12.
[8]	中华医学会内分泌学分会. 甲状腺功能异常新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 13-15.
[9]	中华医学会内分泌学分会. 肾上腺疾病新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 16-17.
[10]	中华医学会内分泌学分会. 垂体疾病新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 18-21.
[11]	中华医学会内分泌学分会. 骨质疏松症新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 22-24.
[12]	中华医学会内分泌学分会. 尿崩症患者新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 25-27.
[13]	欧阳彦, 陈孜瑾, 章倩莹, 陈晓农, 谢静远, 任红, 张文, 王伟铭. 慢性肾脏病人群的新型冠状病毒感染临床诊治建议（瑞金医院2023版）[J]. 内科理论与实践, 2023, 18(01): 28-33.
[14]	高维玲　胡崟清. 新冠疫情下家长陪同对先天性上睑下垂患儿围麻醉期护理效果的研究[J]. 组织工程与重建外科杂志, 2022, 18(4): 339-.
[15]	石峰, 郭竹英, 郭海艳. 新型冠状病毒肺炎患者外周血淋巴细胞亚群变化的临床意义[J]. 诊断学理论与实践, 2022, 21(05): 619-624.